Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
European Journal of Anaesthesiology|March 29, 2019
Efficacy of profound versus moderate neuromuscular blockade in enhancing postoperative recovery after laparoscopic donor nephrectomy: A randomised controlled trialMoira H D Bruintjes, Piet Krijtenburg, Chris H Martini, et al.
Plos One|January 13, 2022
Prospective evaluation of percutaneous hepatic perfusion with melphalan as a treatment for unresectable liver metastases from colorectal cancerT Susanna Meijer, Jan H N Dieters, Eleonora M de Leede, et al.
Trials|February 14, 2022
Combining Hepatic Percutaneous Perfusion with Ipilimumab plus Nivolumab in advanced uveal melanoma (CHOPIN): study protocol for a phase Ib/randomized phase II trialT M L Tong, M K van der Kooij, F M Speetjens, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|October 11, 2021
Pain management, fluid therapy and thromboprophylaxis after pancreatoduodenectomy: a worldwide survey among surgeonsJesse V Groen, Rutger B Henrar, Randa G Hanna Sawires, et al.
Cardiovascular and Interventional Radiology|April 8, 2024
Quality of Life Analysis of Patients Treated with Percutaneous Hepatic Perfusion for Uveal Melanoma Liver MetastasesT M L Tong, M Fiocco, J J van Duijn-de Vreugd, et al.
Annals of Surgical Oncology|August 8, 2020
Percutaneous Hepatic Perfusion with Melphalan in Patients with Unresectable Ocular Melanoma Metastases Confined to the Liver: A Prospective Phase II StudyT Susanna Meijer, Mark C Burgmans, Eleonora M de Leede, et al.
Cardiovascular and Interventional Radiology|January 9, 2023
Combining Melphalan Percutaneous Hepatic Perfusion with Ipilimumab Plus Nivolumab in Advanced Uveal Melanoma: First Safety and Efficacy Data from the Phase Ib Part of the Chopin TrialT M L Tong, M C Burgmans, F M Speetjens, et al.
Clinical and Experimental Immunology|March 14, 2013
Outcomes of splenectomy in patients with common variable immunodeficiency (CVID): a survey of 45 patientsG K Wong, S Goldacker, C Winterhalter, et al.
Pageof 7